UBA1 inhibition contributes radiosensitization of glioblastoma cells via blocking DNA damage repair
Changyong Wu(Xuzhou Medical College), Xuejiao Liu(Xuzhou Medical College)
Cited by 2
Related Papers
CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways
|Journal of Hematology & Oncology|2016|80
MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways
|Frontiers in Oncology|2021|46
RETRACTED ARTICLE: GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death
|Cell Death and Disease|2021|42
MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR‐induced NF‐κB activation
|Journal of Cellular and Molecular Medicine|2020|32
Noncoding RNAs regulating ferroptosis in cardiovascular diseases: novel roles and therapeutic strategies
|Molecular and Cellular Biochemistry|2023|13